Adicet Bio Inc (ACET) stock forecast · rev $2.5M
Adicet Bio Inc (ACET) is a biotechnology company listed on NASDAQ.
This ACET forecast page states what the cached financials imply — not a price target and not a guarantee. Adicet Bio Inc outlooks on Lician start from reported revenue and the latest filing, then you decide.
Latest reported ACET revenue for 2026-06-30 was $2.5M. Net income was -$41.6M. Revenue was up 87.0% from 2026-03-31 to 2026-06-30. ACET currently screens at market cap $75.7M.
The near-term path: Revenue was up 87.0% from 2026-03-31 to 2026-06-30. A forecast that ignores that change is just a story.
ACET currently screens at market cap $75.7M. Stretching today's multiple into 2026 without a filing reason is how thin forecast pages get ignored.
When the next ACET 10-Q or 8-K lands, this outlook should move. Until then the SEC page is the source.
Not a prediction market. For the live quote and the full model, use the ACET stock page.
Not investment advice.